Björn E. Wahlin

3.0k citations

88 papers · 1.5k indexed · h-index 18

Impact in

Pathology and Forensic Medicine top 1%
- Lymphoma Diagnosis and Treatment
Genetics top 5%
- Chronic Lymphocytic Leukemia Research

Papers in

Pathology and Forensic Medicine 60
- Lymphoma Diagnosis and Treatment 60
Genetics 31
- Chronic Lymphocytic Leukemia Research 30

Co-authors: Eva Kimby Birgitta Sander Birger Christensson Harald Holte Bjørn Østenstad Per Ljungman Sandra Lockmer Christer Sundström
Journals: Blood (16 papers)Journal of Clinical Oncology (9 papers)British Journal of Haematology (8 papers)Clinical Cancer Research (5 papers)Medical Oncology (4 papers)
Partner nations: Sweden United States United Kingdom

In The Last Decade

Björn E. Wahlin

85 papers receiving 1.4k citations

Peers

Countries citing papers authored by Björn E. Wahlin

Since Specialization

Citations

This map shows the geographic impact of Björn E. Wahlin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Björn E. Wahlin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Björn E. Wahlin more than expected).

Fields of papers citing papers by Björn E. Wahlin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Björn E. Wahlin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Björn E. Wahlin. The network helps show where Björn E. Wahlin may publish in the future.

Co-authors

The 25 scholars most cited alongside Björn E. Wahlin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Björn E. Wahlin Line = papers co-authored together Björn E. Wahlin links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Subcutaneous epcoritamab + GemOx in patients with relapsed or refractory DLBCL: Updated results from EPCORE NHL-2. Journal of Clinical Oncology ·Joshua Brody, Judit Mészáros Joergensen, David Belada, Régis Costello, Marek Trněný, Umberto Vitolo, David Lewis, Yasmin Karimi, Anna Sureda, Marc André, Björn E. Wahlin, Pieternella J. Lugtenburg, Yajian Jiang, Aqeel Abbas, Yaou Song, Malene Risum, Raúl Córdoba	2024	3
2	Redirecting NK cells to the lymph nodes to augment their lymphoma-targeting capacity npj Precision Oncology ·Laura Sanz-Ortega, Caroline Leijonhufvud, Lisanne Schoutens, Mélanie Lambert, Emily R. Levy, Agneta Andersson, Björn E. Wahlin, Mattias Carlsten	2024	5
3	Matching-adjusted indirect comparisons of zanubrutinib (MAGNOLIA, BGB-3111-AU-003) versus ibrutinib (PCYC-1121) and rituximab (CHRONOS-3) in relapsed/refractory marginal zone lymphoma Leukemia & lymphoma ·Catherine Thieblemont, Björn E. Wahlin, Leyla Mohseninejad, Kaijun Wang, Ina Zhang, Sam Keeping, Keri Yang, Pier Luigi Zinzani	2024	0
4	Long-term Clinical Outcomes in Patients with Waldenström Macroglobulinemia (WM) Who Received Zanubrutinib in the Phase 3 ASPEN Study: A Report from the Zanubrutinib Extension Study Blood ·Shirley D’Sa, Meletios A. Dimopoulos, Wojciech Jurczak, Paula Marlton, Stephen P. Mulligan, Björn E. Wahlin, Magdalena Sobieraj‐Teague, Andrew W. Roberts, Constantine S. Tam, Jorge J. Castillo, Heather Allewelt, Radha Prathikanti, Wai Yee Chan, Tian Tian, Jingjing Schneider, Remus Vezan, Stephen Opat	2024	1
5	2-Arachidonoylglycerol Modulates CXCL12-Mediated Chemotaxis in Mantle Cell Lymphoma and Chronic Lymphocytic Leukemia Cancers ·Magali Merrien, Agata M. Wasik, Christopher M. Melén, Mohammad Hamdy Abdelrazak Morsy, Kristina Sonnevi, Henna‐Riikka Junlén, Birger Christensson, Björn E. Wahlin, Birgitta Sander	2023	4
6	Genetic and transcriptomic analyses of diffuse large B-cell lymphoma patients with poor outcomes within two years of diagnosis Leukemia ·Weicheng Ren, Hui Wan, Sulaf Abd Own, Mattias Berglund, Xianhuo Wang, Ming‐Yu Yang, Xiaobo Li, Dongbing Liu, Xiaofei Ye, Kristina Sonnevi, Gunilla Enblad, Rose‐Marie Amini, Birgitta Sander, Kui Wu, Huilai Zhang, Björn E. Wahlin, Karin E. Smedby, Qiang Pan‐Hammarström	2023	9
7	Parsaclisib, a PI3Kδ inhibitor, in relapsed and refractory follicular lymphoma (CITADEL-203): a phase 2 study EClinicalMedicine ·Marek Trněný, Abraham Avigdor, Matthew McKinney, Shankara Paneesha, Björn E. Wahlin, John Hrom, David Cunningham, Nicholas Morley, Miguel Canales, Mariana Bastos‐Oreiro, David Belada, Liliana Devizzi, Fred Zheng, Douglas J. DeMarini, Wei Jiang, Ping Jiang, Ryan C. Lynch	2023	3
8	Impact of COVID-19 on patients treated with autologous hematopoietic stem cell transplantation: A retrospective cohort study Upsala Journal of Medical Sciences ·Thomas Silfverberg, Björn E. Wahlin, Kristina Carlson, Honar Cherif	2022	3
9	The role of BAFF and G-CSF for rituximab-induced late-onset neutropenia (LON) in lymphomas Medical Oncology ·Daniel Tesfa, Birgitta Sander, Henric Lindkvist, Christer Nilsson, Eva Kimby, Hans Hägglund, Björn E. Wahlin, Monika Klimkowska, Jan Palmblad	2021	4
10	Complete Remission with Reduction of High-Risk Clones following Haploidentical NK-Cell Therapy against MDS and AML Clinical Cancer Research ·Andreas T. Björklund, Mattias Carlsten, Ebba Sohlberg, Lisa L. Liu, Trevor Clancy, Mohsen Karimi, Sarah Cooley, Jeffrey S. Miller, Monika Klimkowska, Marie Schaffer, Emma Watz, Kristina Wikström, Pontus Blomberg, Björn E. Wahlin, Marzia Palma, Lotta Hansson, Per Ljungman, Eva Hellström-Lindberg, Hans‐Gustaf Ljunggren, Karl‐Johan Malmberg	2018	141
11	Long‐term survival and loss in expectancy of life in a population‐based cohort of 7114 patients with diffuse large B‐cell lymphoma American Journal of Hematology ·Sara Ekberg, Mats Jerkeman, Per‐Ola Andersson, Gunilla Enblad, Björn E. Wahlin, Sverker Hasselblom, Therése Andersson, Sandra Eloranta, Karin E. Smedby	2018	19
12	T-Cell Levels Are Prognostic in Mantle Cell Lymphoma Clinical Cancer Research ·Lina Nygren, Agata M. Wasik, Stefanie Baumgartner-Wennerholm, Åsa Jeppsson-Ahlberg, Monika Klimkowska, Patrik Andersson, Daren Buhrkuhl, Birger Christensson, Eva Kimby, Björn E. Wahlin, Birgitta Sander	2014	34
13	Clinical utility of different bone marrow examination methods in the diagnosis of adults with sporadic Gaucher disease type 1 Polskie Archiwum Medycyny Wewnętrznej ·Maciej Machaczka, Alicja Markuszewska-Kuczyńska, Sofie Regenthal, Artur Jurczyszyn, Krystyna Gałązka, Björn E. Wahlin, Monika Klimkowska	2014	8
14	Follicular lymphoma in Sweden: nationwide improved survival in the rituximab era, particularly in elderly women: a Swedish Lymphoma Registry Study Leukemia ·Henna Riikka Junlén, Stefan Peterson, Eva Kimby, Sandra Lockmer, O. Lindén, Herman Nilsson‐Ehle, Martin Erlanson, Hans Hagberg, Anders Rådlund, Oskar Hagberg, Björn E. Wahlin	2014	95
15	Higher World Health Organization grades of follicular lymphoma correlate with better outcome in two Nordic Lymphoma Group trials of rituximab without chemotherapy Leukemia & lymphoma ·Björn E. Wahlin, Christer Sundström, Birgitta Sander, Birger Christensson, Åsa Jeppsson-Ahlberg, Eric Hjalmarsson, Harald Holte, Bjørn Østenstad, Peter de Nully Brown, Erlend B. Smeland, Eva Kimby	2013	11
16	High incidence of chronic graft-versus-host disease after myeloablative allogeneic stem cell transplantation for chronic lymphocytic leukemia in Sweden: graft-versus-leukemia effect protects against relapse Medical Oncology ·Maciej Machaczka, Jan‐Erik Johansson, Mats Remberger, Heléne Hallböök, Vladimir Lazarević, Björn E. Wahlin, Hamdy Omar, Anders Wåhlin, Gunnar Juliusson, Eva Kimby, Hans Hägglund	2013	2
17	T Cells in Tumors and Blood Predict Outcome in Follicular Lymphoma Treated with Rituximab Clinical Cancer Research ·Björn E. Wahlin, Christer Sundström, Harald Holte, Hans Hagberg, Martin Erlanson, Herman Nilsson‐Ehle, Ola Lindén, Marie Nordström, Bjørn Østenstad, Christian H. Geisler, Peter de Nully Brown, Tuula Lehtinen, Martin Maisenhölder, Anne Tierens, Birgitta Sander, Birger Christensson, Eva Kimby	2011	41
18	Clinical significance of the WHO grades of follicular lymphoma in a population‐based cohort of 505 patients with long follow‐up times British Journal of Haematology ·Björn E. Wahlin, Olav Erich Yri, Eva Kimby, Harald Holte, Jan Delabie, Erlend B. Smeland, Christer Sundström, Birger Christensson, Birgitta Sander	2011	90
19	Autologous hematopoietic stem cell transplantation in multiple myeloma and lymphoma: an analysis of factors influencing stem cell collection and hematological recovery Medical Oncology ·Johanna Ungerstedt, Emma Watz, Katarina Uttervall, B-M Johansson, Björn E. Wahlin, Per Näsman, Per Ljungman, Astrid Gruber, Ulla Axdorph Nygell, Hareth Nahi	2011	19
20	Ribavirin therapy in bone marrow transplant recipients with viral respiratory tract infections Bone Marrow Transplantation ·E. Sparrelid, Per Ljungman, E Ekelöf-Andström, J Aschan, Olle Ringdén, Jacek Winiarski, Björn E. Wahlin, Jan Andersson	1997	89

About Björn E. Wahlin

Björn E. Wahlin is a scholar working on Pathology and Forensic Medicine, Genetics, Oncology, Neurology and Immunology, having authored 88 papers that have together received 1.5k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (60 papers), Chronic Lymphocytic Leukemia Research (30 papers), CAR-T cell therapy research (19 papers), CNS Lymphoma Diagnosis and Treatment (16 papers), Viral-associated cancers and disorders (13 papers), Immune Cell Function and Interaction (13 papers), Monoclonal and Polyclonal Antibodies Research (12 papers) and Cannabis and Cannabinoid Research (5 papers). The work is most often cited by research in Pathology and Forensic Medicine (869 citations), Genetics (337 citations), Oncology (830 citations), Immunology (493 citations) and Hematology (151 citations). Björn E. Wahlin has collaborated with scholars based in Sweden, United States and United Kingdom. Frequent co-authors include Eva Kimby, Birgitta Sander, Birger Christensson, Harald Holte, Bjørn Østenstad, Per Ljungman, Sandra Lockmer, Christer Sundström, Hans Hagberg and Erlend B. Smeland. Their work appears in journals such as Blood, Journal of Clinical Oncology, British Journal of Haematology, Clinical Cancer Research and Medical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact